-
Je něco špatně v tomto záznamu ?
Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates
AJLM. Geraerds, W. van Herk, M. Stocker, S. El Helou, S. Dutta, MS. Fontana, FABA. Schuerman, RK. van den Tooren-de Groot, J. Wieringa, J. Janota, LH. van der Meer-Kappelle, R. Moonen, SD. Sie, E. de Vries, AE. Donker, U. Zimmerman, LJ....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
NLK
BioMedCentral
od 1997-04-01
BioMedCentral Open Access
od 1997
Directory of Open Access Journals
od 1998
Free Medical Journals
od 1997
PubMed Central
od 1997
Europe PubMed Central
od 1997
ProQuest Central
od 2015-01-01
Open Access Digital Library
od 1997-01-01
Open Access Digital Library
od 1997-08-01
Open Access Digital Library
od 1998-01-01
Medline Complete (EBSCOhost)
od 2011-02-01
Health & Medicine (ProQuest)
od 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1997
Springer Nature OA/Free Journals
od 1997-04-01
- MeSH
- antibakteriální látky * terapeutické užití MeSH
- časná diagnóza MeSH
- klinické rozhodování * metody MeSH
- lidé MeSH
- náklady na zdravotní péči * statistika a číselné údaje MeSH
- novorozenec MeSH
- prokalcitonin krev MeSH
- sepse * diagnóza farmakoterapie MeSH
- trvání terapie * MeSH
- Check Tag
- lidé MeSH
- novorozenec MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUNDS: The large, international, randomized controlled NeoPInS trial showed that procalcitonin (PCT)-guided decision making was superior to standard care in reducing the duration of antibiotic therapy and hospitalization in neonates suspected of early-onset sepsis (EOS), without increased adverse events. This study aimed to perform a cost-minimization study of the NeoPInS trial, comparing health care costs of standard care and PCT-guided decision making based on the NeoPInS algorithm, and to analyze subgroups based on country, risk category and gestational age. METHODS: Data from the NeoPInS trial in neonates born after 34 weeks of gestational age with suspected EOS in the first 72 h of life requiring antibiotic therapy were used. We performed a cost-minimization study of health care costs, comparing standard care to PCT-guided decision making. RESULTS: In total, 1489 neonates were included in the study, of which 754 were treated according to PCT-guided decision making and 735 received standard care. Mean health care costs of PCT-guided decision making were not significantly different from costs of standard care (€3649 vs. €3616). Considering subgroups, we found a significant reduction in health care costs of PCT-guided decision making for risk category 'infection unlikely' and for gestational age ≥ 37 weeks in the Netherlands, Switzerland and the Czech Republic, and for gestational age < 37 weeks in the Czech Republic. CONCLUSIONS: Health care costs of PCT-guided decision making of term and late-preterm neonates with suspected EOS are not significantly different from costs of standard care. Significant cost reduction was found for risk category 'infection unlikely,' and is affected by both the price of PCT-testing and (prolonged) hospitalization due to SAEs.
Department of Neonatology Albert Schweitzer Hospital Dordrecht The Netherlands
Department of Neonatology Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands
Department of Neonatology Reinier de Graaf Gasthuis Delft The Netherlands
Department of Neonatology Sint Franciscus Gasthuis Rotterdam The Netherlands
Department of Neonatology St Josephs Healthcare Hamilton Health Sciences Hamilton ON Canada
Department of Neonatology Zuyderland Medical Centre Heerlen The Netherlands
Department of Paediatrics Bern University Hospital Inselspital University of Bern Bern Switzerland
Department of Paediatrics Haaglanden Medical Center 's Gravenhage The Netherlands
Department of Paediatrics Jeroen Bosch Hospital 's Hertogenbosch The Netherlands
Department of Paediatrics Kantonsspital Winterthur Winterthur Switzerland
Department of Paediatrics Maxima Medical Centre Veldhoven The Netherlands
Department of Paediatrics Stadtspital Triemli Zürich Switzerland
Institute of Pathological Physiology 1st Medical Faculty Charles University Prague Czech Republic
Julius Training General Practitioner University Medical Centre Utrecht Utrecht The Netherlands
Neonatal Intensive Care Unit Isala Women and Children's Centre Isala Hospital Zwolle The Netherlands
Paediatric Intensive Care Unit Lady Cilento Children's Hospital Brisbane QLD Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22003437
- 003
- CZ-PrNML
- 005
- 20220127150233.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13054-021-03789-x $2 doi
- 035 __
- $a (PubMed)34670582
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Geraerds, A J L M $u Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. a.geraerds@erasmusmc.nl
- 245 10
- $a Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates / $c AJLM. Geraerds, W. van Herk, M. Stocker, S. El Helou, S. Dutta, MS. Fontana, FABA. Schuerman, RK. van den Tooren-de Groot, J. Wieringa, J. Janota, LH. van der Meer-Kappelle, R. Moonen, SD. Sie, E. de Vries, AE. Donker, U. Zimmerman, LJ. Schlapbach, AC. de Mol, A. Hoffman-Haringsma, M. Roy, M. Tomaske, RF. Kornelisse, J. van Gijsel, EG. Visser, AMC. van Rossum, S. Polinder
- 520 9_
- $a BACKGROUNDS: The large, international, randomized controlled NeoPInS trial showed that procalcitonin (PCT)-guided decision making was superior to standard care in reducing the duration of antibiotic therapy and hospitalization in neonates suspected of early-onset sepsis (EOS), without increased adverse events. This study aimed to perform a cost-minimization study of the NeoPInS trial, comparing health care costs of standard care and PCT-guided decision making based on the NeoPInS algorithm, and to analyze subgroups based on country, risk category and gestational age. METHODS: Data from the NeoPInS trial in neonates born after 34 weeks of gestational age with suspected EOS in the first 72 h of life requiring antibiotic therapy were used. We performed a cost-minimization study of health care costs, comparing standard care to PCT-guided decision making. RESULTS: In total, 1489 neonates were included in the study, of which 754 were treated according to PCT-guided decision making and 735 received standard care. Mean health care costs of PCT-guided decision making were not significantly different from costs of standard care (€3649 vs. €3616). Considering subgroups, we found a significant reduction in health care costs of PCT-guided decision making for risk category 'infection unlikely' and for gestational age ≥ 37 weeks in the Netherlands, Switzerland and the Czech Republic, and for gestational age < 37 weeks in the Czech Republic. CONCLUSIONS: Health care costs of PCT-guided decision making of term and late-preterm neonates with suspected EOS are not significantly different from costs of standard care. Significant cost reduction was found for risk category 'infection unlikely,' and is affected by both the price of PCT-testing and (prolonged) hospitalization due to SAEs.
- 650 12
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 650 12
- $a klinické rozhodování $x metody $7 D000066491
- 650 12
- $a trvání terapie $7 D000081206
- 650 _2
- $a časná diagnóza $7 D042241
- 650 12
- $a náklady na zdravotní péči $x statistika a číselné údaje $7 D017048
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a prokalcitonin $x krev $7 D000077740
- 650 12
- $a sepse $x diagnóza $x farmakoterapie $7 D018805
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a van Herk, Wendy $u Division of Paediatric Infectious Diseases & Immunology, Department of Paediatrics, Erasmus MC University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands
- 700 1_
- $a Stocker, Martin $u Department of Paediatrics, Neonatal and Paediatric Intensive Care Unit, Children's Hospital Lucerne, Lucerne, Switzerland
- 700 1_
- $a El Helou, Salhab $u Division of Neonatology, McMaster University Children's Hospital, Hamilton Health Sciences, Hamilton, ON, Canada
- 700 1_
- $a Dutta, Sourabh $u Division of Neonatology, McMaster University Children's Hospital, Hamilton Health Sciences, Hamilton, ON, Canada
- 700 1_
- $a Fontana, Matteo S $u Department of Paediatrics, Neonatal and Paediatric Intensive Care Unit, Children's Hospital Lucerne, Lucerne, Switzerland
- 700 1_
- $a Schuerman, Frank A B A $u Neonatal Intensive Care Unit, Isala Women and Children's Centre, Isala Hospital, Zwolle, The Netherlands
- 700 1_
- $a van den Tooren-de Groot, Rita K $u Department of Paediatrics, Haaglanden Medical Center, 's Gravenhage, The Netherlands
- 700 1_
- $a Wieringa, Jantien $u Department of Paediatrics, Haaglanden Medical Center, 's Gravenhage, The Netherlands
- 700 1_
- $a Janota, Jan $u Neonatal Unit, Department of Obstetrics and Gynaecology, Motol University Hospital, Second Medical Faculty, Charles University, Prague, Czech Republic $u Institute of Pathological Physiology, First Medical Faculty, Charles University, Prague, Czech Republic
- 700 1_
- $a van der Meer-Kappelle, Laura H $u Department of Neonatology, Reinier de Graaf Gasthuis, Delft, The Netherlands
- 700 1_
- $a Moonen, Rob $u Department of Neonatology, Zuyderland Medical Centre, Heerlen, The Netherlands
- 700 1_
- $a Sie, Sintha D $u Department of Neonatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
- 700 1_
- $a de Vries, Esther $u Department of Paediatrics, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands
- 700 1_
- $a Donker, Albertine E $u Department of Paediatrics, Maxima Medical Centre, Veldhoven, The Netherlands
- 700 1_
- $a Zimmerman, Urs $u Department of Paediatrics, Kantonsspital Winterthur, Winterthur, Switzerland
- 700 1_
- $a Schlapbach, Luregn J $u Department of Paediatrics, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland $u Paediatric Critical Care Research Group, Mater Research Institute, University of Queensland, Brisbane, QLD, Australia $u Paediatric Intensive Care Unit, Lady Cilento Children's Hospital, Brisbane, QLD, Australia
- 700 1_
- $a de Mol, Amerik C $u Department of Neonatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands
- 700 1_
- $a Hoffman-Haringsma, Angelique $u Department of Neonatology, Sint Franciscus Gasthuis, Rotterdam, The Netherlands
- 700 1_
- $a Roy, Madan $u Department of Neonatology, St. Josephs Healthcare, Hamilton Health Sciences, Hamilton, ON, Canada
- 700 1_
- $a Tomaske, Maren $u Department of Paediatrics, Stadtspital Triemli, Zürich, Switzerland
- 700 1_
- $a Kornelisse, René F $u Division of Neonatology, Erasmus MC University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands
- 700 1_
- $a van Gijsel, Juliette $u Julius Training General Practitioner, University Medical Centre Utrecht, Utrecht, The Netherlands
- 700 1_
- $a Visser, Eline G $u Division of Paediatric Infectious Diseases & Immunology, Department of Paediatrics, Erasmus MC University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands
- 700 1_
- $a van Rossum, Annemarie M C $u Division of Paediatric Infectious Diseases & Immunology, Department of Paediatrics, Erasmus MC University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands
- 700 1_
- $a Polinder, Suzanne $u Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands
- 773 0_
- $w MED00006603 $t Critical care (London, England) $x 1466-609X $g Roč. 25, č. 1 (2021), s. 367
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34670582 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127150229 $b ABA008
- 999 __
- $a ok $b bmc $g 1751021 $s 1154586
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 25 $c 1 $d 367 $e 20211020 $i 1466-609X $m Critical care $n Crit Care $x MED00006603
- LZP __
- $a Pubmed-20220113